Arbital Health has secured $31 million to advance its value-based care contracting solutions that are designed to support healthcare providers and payers. Valtruis led the Series B funding round and existing investors Transformation Capital, Shaper Capital and Healthy Ventures also participated.
Value-based care contracts are agreements that incentivize quality, effective patient care. Through its AI-powered platform, Arbital Health aims to deliver tools that streamline performance monitoring and simplify management of complex risk-based contracts. The new capital will be put toward expanding that technology, enhancing the company’s benchmarking capabilities and growing its team of actuarial experts.
“By enabling our clients to better monitor, manage, and reconcile risk-based contracts, we’re helping them make smarter decisions, reduce financial risk and improve patient outcomes. This new funding will accelerate our mission to transform how the industry manages value-based care,” Arbital Health Co-Founder, President and CEO Brian Overstreet said in a statement.
